Studylog
Private Company
Total funding raised: $2M
Overview
Studylog is a long-established leader in animal study workflow software, offering a configurable platform that digitizes and standardizes preclinical research from planning to reporting. Its core value proposition is enhancing data integrity, protocol adherence, and experimental throughput by replacing error-prone manual methods like spreadsheets with automated, integrated systems. The company has successfully penetrated the top tier of the pharmaceutical industry and is now positioning its structured data output as essential for future AI-driven discovery, aiming to future-proof research data. As a private company, it operates on a software licensing model, serving a global customer base in the life sciences.
Technology Platform
A configurable desktop software platform for managing the complete animal study workflow, featuring study design, automated data acquisition from lab devices, randomization, task scheduling, integrated analysis/reporting, and one-click export to GraphPad Prism. It emphasizes data integrity, reproducibility, and structuring data for AI analysis.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Studylog competes with generic electronic lab notebooks (ELNs) and laboratory information management systems (LIMS), but its specialization in complex in-vivo study workflows is a key differentiator. Direct competitors likely include other preclinical study management software vendors, but Studylog's 20+ year history, deep pharma penetration, and focus on device integration and AI-readiness provide strong competitive moats. The most significant competition often comes from internally developed systems or the entrenched use of manual spreadsheets.